Learning Objectives

  1. Describe the clinical manifestation, updated diagnostic criteria, and risk stratification of Kawasaki Disease (KD)
  2. Evaluate latest evidence-based treatment recommendations for first-line, intensification, and IVIg-resistant therapy for KD
  3. Recognize long-term thromboprophylaxis management strategies for prevention of future episodes of KD
Session date: 
04/22/2025 - 2:00pm to 3:00pm EDT
Add to calendar: 
  • 1.00 ACPE Pharmacist
    Children's National Hospital is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program meets ACPE criteria for 1.00 contact hours.
  • 1.00 ACPE Technician
    Children's National Hospital is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program meets ACPE criteria for 1.00 contact hours.
  • 1.00 Participation
    Successful completion of this continuing education activity.
Please login or register to take this course.
Faculty List: 
Course Director(s)

Alexander Wang, PharmD

has no relevant financial relationships to disclose at this time.
Speaker(s)

Benjamin Davic, BS, PharmD

has no relevant financial relationships to disclose at this time.